Summary: This report describes successful surgical correction and long‐term survival of a case of large colon atresia in a 24‐h‐old Warmblood colt, referred with signs of unrelenting abdominal pain and a suspicion of meconium impaction. Radiographic and ultrasonographic examination was indicative of large colon meconium impaction with secondary ileus. Due to deterioration of the foal, surgery was recommended. An atretic segment was found between the left ventral and dorsal large (ascending) colon. A band of fibrous tissue with no identifiable lumen connected the segments. Surgical correction was done by performing a stapled side‐to‐side anastomosis. Twelve days after surgery, the foal was discharged. Twenty‐two months after discharge, the owner reported the foal developing as expected compared with its peers, but had a mild, self‐limiting episode of colic at 20 months of age.
Sulfasalazine is an azo-linked prodrug of sulfapyridine and 5-aminosalicylic acid that is activated by bacterial azoreductases in the distal gut. Its disposition has not been described in horses, in which extensive hindgut fermentation may influence prodrug activation. This study characterised the concentration-time profile of sulfasalazine and the appearance of sulfapyridine, 5-hydroxy-sulfapyridine and N4-acetyl-sulfapyridine after a single oral dose. Six healthy adult Warmblood horses received sulfasalazine (16 mg/kg) by nasogastric tube, and blood was sampled hourly for 14 h. Sulfasalazine and sulfapyridine were quantified by liquid chromatography-tandem mass spectrometry; both metabolites were assessed semi-quantitatively as peak-area ratios. Sulfasalazine was measurable from 1 h and reached a median maximum concentration of 386.61 ng/mL (Q1–Q3 330.44–504.35) at a median of 5.5 h, then declined steeply. Sulfapyridine remained near the limit of detection for six hours, rose abruptly between 7 and 8 h and peaked at a median of 2794.00 ng/mL (2381.87–3146.14) at 9.0 h, approximately seven-fold above the parent-drug maximum. Both metabolites rose in parallel with sulfapyridine. This timing matches published equine orocaecal transit times, indicating that sulfasalazine reaches the hindgut largely intact and is activated there by microbial azoreduction. Systemic sulfapyridine exposure was substantial and should be considered in any therapeutic use.